Cargando…
Hexamethylene bisacetamide impairs NK cell-mediated clearance of acute T lymphoblastic leukemia cells and HIV-1-infected T cells that exit viral latency
The hexamethylene bisacetamide (HMBA) anticancer drug was dismissed due to limited efficacy in leukemic patients but it may re-enter into the clinics in HIV-1 eradication strategies because of its recently disclosed capacity to reactivate latent virus. Here, we investigated the impact of HMBA on the...
Autores principales: | Giuliani, Erica, Desimio, Maria Giovanna, Doria, Margherita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416400/ https://www.ncbi.nlm.nih.gov/pubmed/30867508 http://dx.doi.org/10.1038/s41598-019-40760-x |
Ejemplares similares
-
Enhancement of the radiosensitivity of two human tumour cell lines by hexamethylene bisacetamide.
por: Bill, C. A., et al.
Publicado: (1990) -
Combinations of Histone Deacetylase Inhibitors with Distinct Latency Reversing Agents Variably Affect HIV Reactivation and Susceptibility to NK Cell-Mediated Killing of T Cells That Exit Viral Latency
por: Covino, Daniela A., et al.
Publicado: (2021) -
Induced differentiation of erythroleukemia cells by hexamethylene bisacetamide: a model for cytodifferentiation of transformed cells.
por: Marks, P A, et al.
Publicado: (1989) -
Impact of IL-15 and latency reversing agent combinations in the reactivation and NK cell-mediated suppression of the HIV reservoir
por: Covino, Daniela Angela, et al.
Publicado: (2022) -
Potential of the NKG2D/NKG2DL Axis in NK Cell-Mediated Clearance of the HIV-1 Reservoir
por: Desimio, Maria G., et al.
Publicado: (2019)